Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Forgez

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Peptides|August 8, 2006
Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulationFrédérique Souazé, Patricia Forgez
The Journal of Thoracic and Cardiovascular Surgery|September 18, 2013
Reply to the editorMariette Baud, Patricia Forgez, Diane Damotte, et al.
Biochemical and Biophysical Research Communications|August 2, 2002
Neurotensin counteracts apoptosis in breast cancer cellsSonia Somaï, Anne Gompel, William Rostène, et al.
Biochimie|April 20, 2020
Renin-angiotensin system at the heart of COVID-19 pandemicMarco Alifano, Pietro Alifano, Patricia Forgez, et al.
Frontiers in Endocrinology|January 22, 2013
Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapyZherui Wu, Daniel Martinez-Fong, Jean Trédaniel, et al.
Molecular Pharmacology|August 16, 2002
Neurotensin induces tyrosine hydroxylase gene activation through nitric oxide and protein kinase C signaling pathwaysMustapha Najimi, Jean-Jacques Robert, Jacques Mallet, et al.
Biochimie|November 12, 2020
Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike proteinMatteo Calcagnile, Patricia Forgez, Antonio Iannelli, et al.
Breast Cancer Research and Treatment|August 6, 2011
Glucocorticoid receptor and breast cancerMyriam Vilasco, Laudine Communal, Najat Mourra, et al.
One Health (Amsterdam, Netherlands)|November 29, 2021
Codon usage, phylogeny and binding energy estimation predict the evolution of SARS-CoV-2Matteo Calcagnile, Tiziano Verri, Maurizio Salvatore Tredici, et al.
Biochimie|May 25, 2011
The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancersSandra Dupouy, Najat Mourra, Van Kien Doan, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Peptides|August 8, 2006
Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulationFrédérique Souazé, Patricia Forgez
The Journal of Thoracic and Cardiovascular Surgery|September 18, 2013
Reply to the editorMariette Baud, Patricia Forgez, Diane Damotte, et al.
Biochemical and Biophysical Research Communications|August 2, 2002
Neurotensin counteracts apoptosis in breast cancer cellsSonia Somaï, Anne Gompel, William Rostène, et al.
Biochimie|April 20, 2020
Renin-angiotensin system at the heart of COVID-19 pandemicMarco Alifano, Pietro Alifano, Patricia Forgez, et al.
Frontiers in Endocrinology|January 22, 2013
Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapyZherui Wu, Daniel Martinez-Fong, Jean Trédaniel, et al.
Molecular Pharmacology|August 16, 2002
Neurotensin induces tyrosine hydroxylase gene activation through nitric oxide and protein kinase C signaling pathwaysMustapha Najimi, Jean-Jacques Robert, Jacques Mallet, et al.
Biochimie|November 12, 2020
Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike proteinMatteo Calcagnile, Patricia Forgez, Antonio Iannelli, et al.
Breast Cancer Research and Treatment|August 6, 2011
Glucocorticoid receptor and breast cancerMyriam Vilasco, Laudine Communal, Najat Mourra, et al.
One Health (Amsterdam, Netherlands)|November 29, 2021
Codon usage, phylogeny and binding energy estimation predict the evolution of SARS-CoV-2Matteo Calcagnile, Tiziano Verri, Maurizio Salvatore Tredici, et al.
Biochimie|May 25, 2011
The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancersSandra Dupouy, Najat Mourra, Van Kien Doan, et al.
Pageof 5